Concentrix (CNXC) Q2 2026 earnings review
A Clean Print, A Quiet Guidance Cut
Revenue landed in-guidance at $2.46B (+1.9% reported, +0.6% constant currency), and the headline GAAP EPS jumped 37% to $0.86. But the EPS pop is an illusion: it's flattered by a ~$45M foreign-currency gain. The cleaner non-GAAP EPS of $2.63 actually fell 2.6% year-over-year. The real news was buried in the outlook: management cut both the full-year revenue and margin guides. Offshoring is now draining ~300bps from revenue (up from 200bps assumed), and the long-promised margin recovery slipped to the second half yet again. The one bright spot: a record Q2 free cash flow of $242M restored credibility to the cash story after a scary Q1.
🐂 Bull Case
Adjusted free cash flow hit a record-high second quarter of $242M (+21% YoY). After Q1's alarming -$145M, first-half FCF is now positive $98M, and the $630-650M full-year guide was reaffirmed. Management is steering all of it toward debt reduction.
Management says clients using the iX Suite carry ~350bps higher margins and grow faster than the consolidated average, with 11% of revenue now 'influenced' by these deployments. iX Suite deal count rose 400% YoY. (Figures are management assertions, not independently verifiable from the financials.)
🐻 Bear Case
FY26 constant-currency revenue growth was cut to 0.25-1.25% (from 1.5-3.0%) and NGOI to $1,200-1,230M (from $1,240-1,290M). The cause is structural—accelerated offshoring now a ~300bps headwind—not a one-off. The expected inflection got pushed out.
Non-GAAP EPS dropped 2.6% to $2.63. The 37% GAAP EPS jump was driven by a ~$45M FX gain in other income, not operations. GAAP operating margin actually fell to 3.9% from 6.1% as restructuring charges quadrupled to $66M.
⚖️ Verdict: 🔴
Bearish. The quarter cleared the low bar of in-line revenue and rescued the cash story, but it quietly cut full-year guidance, pushed the margin recovery out for a fifth straight quarter, and the only genuine EPS strength came from currency. Restored FCF prevents a 'very bearish' score; deteriorating fundamentals prevent 'neutral'.
Key Themes
Offshoring Headwind Turned Structural and Accelerated
The single most important item on the call, invisible in the press release tables. CFO Valentine said the FY revenue guide was reduced primarily because the mix-shift to offshore delivery is now a ~300bps drag versus the 200bps previously assumed, plus ~100bps from clients dropping customer segments entirely. CEO Caldwell said the inflection 'originally guided to later this year' is getting pushed out, and guided the offshore funnel to keep shrinking 1.5-2.5% next year—making this a multi-year reported-revenue suppressant, not a one-off. Management argues it is gross-margin-accretive after two-to-three quarters of duplicate costs, a claim worth tracking but not yet proven.
Margin Recovery Deferred for a Fifth Straight Quarter
The 'sequential ramp next half' commitment has now persisted across five consecutive quarters while margins kept compressing. Q2 NGOI margin was 11.9%, up only 10bps from Q1's 11.8%—technically improving, but trivially. The bar was also quietly lowered: the win condition is now merely 'up vs H2'25,' an easy comp because H2'25 carried tariff and labor-holding drag. The full-year midpoint (12.2%) requires Q3 at ~12.1% and a Q4 print near 13%—the same back-loaded shape that has missed before. The annual trajectory is stark: 14.2% (2023) to 12.2% guided (2026).
iX Suite: The Bull Leg Gets Its First Margin Evidence
The clearest positive on the call. Caldwell raised the iX Suite target to roughly double, surpassing ~$120M annual recurring revenue by year-end. More substantively, and new this quarter: clients with iX Suite deployed grow faster than the consolidated average and carry almost 350bps better margin, subscription revenue from already-deployed clients grew 24% YoY, and 11% of total revenue is now 'influenced by' iX Suite. Of the top 75% of clients, 97% have AI in production. This is the first hard data point that the mix-shift is margin-accretive rather than merely revenue-neutral—but at ~1-2% of revenue, it remains a promise, not yet a mover. All percentages here are management assertions without third-party confirmation.
Vendor Consolidation Stalled This Quarter
A load-bearing bull vector from prior quarters weakened. Asked directly, Caldwell said the company 'didn't see much' consolidation in Q2 and doesn't 'expect much' in Q3, with the next wave pushed to year-end in consumer electronics, social media, and telecom after the holiday season. Consolidation had been a top strengthening theme across the prior year; its stall removes near-term support for the share-gain narrative.
BFSI and Retail Are Carrying the Top Line
Two verticals are doing the heavy lifting, and both are the kind of complex, offshore-resistant work the strategy targets. BFSI grew 12.6% YoY to $432M—Caldwell expects 'high single-digit, low double-digit' to persist, driven by a shift into transformational deals. Retail/Travel/E-commerce grew 9.8% to $641M. Valentine explicitly noted these areas 'tend to be less impacted by shore movement,' which is why they held up while consumer electronics and telecom absorbed the offshoring hit. They are the structural offset to the declining legacy verticals.
Healthcare Decline Accelerating, Unaddressed
The standout red flag, and the data point that most contradicts the 'high-quality, AI-enabled growth' narrative. Healthcare fell 13.9% YoY to $152M—a deceleration from -10% across the first half. It has been a self-identified weakness for six straight quarters with no corrective plan or measurable milestones articulated; management attributes it to reduced open-enrollment participation (Medicare/ACA). Tech & Consumer Electronics (-5.8%) and Communications & Media (-0.2%) are also negative, concentrating the weakness in exactly the segments where automation and offshore migration bite hardest.
Capital Allocation Pivots from Buybacks to Deleveraging
A real change in posture. The company repurchased zero shares this quarter (after buying aggressively at $40-42 through the trough), redirecting cash entirely to debt reduction—net debt fell $228M to ~$4.32B. Management reiterated <2.6x net leverage by year-end and added a new FY27 frame: net debt below $3.3B (~2.2x) with FCF exceeding FY26. This de-risks the balance sheet but abandons the counter-cyclical buyback signal that previously underpinned the stewardship case. Valentine called FCF 'the thing we're most confident in.'
Restructuring Charges Larger Than Planned
GAAP operating income fell 36% to $95M (margin 3.9% vs 6.1%), driven by acquisition/integration/restructuring expenses quadrupling to $66M as the company accelerates internal AI automation and offshore moves. Full-year restructuring is now guided to $175M ($45M in Q3, $30M in Q4). Management says it covers the cash cost in six-to-nine months and still hits the FCF guide, but a higher-than-anticipated charge mid-strategy warrants monitoring.
Internal AI Efficiency Driving Margin Defense
The specific cost-discipline mechanism funding the strategy. Concentrix deployed its own AI tools internally this quarter, growing revenue per non-billable headcount 14% YoY even while adding net new staff in technology areas. Implementation speed on iX Suite deployments improved 12% through the quarter. This internal automation—distinct from the client-facing iX revenue—is the lever management is pulling to expand margin in higher-value areas while reducing cost elsewhere, and it is a genuine driver of the targeted second-half margin improvement rather than a top-line story.
Other KPIs
A textbook case of a misleading headline. GAAP diluted EPS surged 37% YoY, but the gain came almost entirely from a ~$45M foreign-currency gain in other income ($0.74/share), not operations. The cleaner non-GAAP EPS—which strips the FX noise—fell 2.6% to $2.63 (from $2.70), the truer read on operating performance. Investors anchoring on the GAAP number would draw the wrong conclusion.
A record second quarter, up 21% from $200.3M. Operating cash flow was $258M against just $48M capex. Critically, this reverses the Q1 scare: first-half adjusted FCF swung to +$98M, making the reaffirmed $630-650M full-year guide credible (H2 needs ~$542M, plausible given Q4 seasonality). Note the $33M factoring add-back continues to do meaningful work in the adjusted figure—worth confirming the factoring program isn't growing in ways that flatter the metric.
Down $230M YoY and $228M sequentially. Total debt is ~$4.585B against ~$263M cash. Included is $200M of senior notes due August 2026 and $375M of term loans due December 2026, both to be repaid with second-half free cash flow—over $550M in total debt paydown planned this year. The path to <2.6x leverage by year-end is the firm's stated priority over buybacks.
Guidance
Decelerating / cut. This is a material reduction from the prior 1.5-3.0% range. Valentine attributed it primarily to offshoring now representing a ~300bps headwind (up from 200bps assumed) plus ~100bps of client de-scoping. Reported revenue of $9.925-10.025B implies just 1.0-2.0% growth, decelerating from 1.9% in Q2. The cut is structural, not seasonal.
Decelerating / cut. Midpoint falls $50M to $1,215M, implying a 12.2% margin—down ~30bps from the prior ~12.5% implied guide and continuing the five-year compression from 14.2% in 2023. Ruplu (BofA) pinned the cut on the call; Valentine tied it to the revenue pull-down and offshore duplicate costs.
Stable / flat. Q3 implies 0.0-1.0% constant-currency growth and a 12.0-12.2% NGOI margin midpoint (~12.1%)—only marginally above Q2's 11.9%. The recovery is once again deferred to Q4, which the full-year math requires to land near 13%, a sharp sequential step-up off the Q3 base.
Reaffirmed despite the revenue and margin cuts, and notably this is after the elevated $175M restructuring spend. With $98M booked in 1H, the guide needs ~$542M in 2H—consistent with the company's typical Q4-heavy cash seasonality. Management flagged FY27 FCF would exceed FY26, enabling another >$550M of debt paydown.
Key Questions
When Does the Offshore Margin Benefit Actually Show Up?
Caldwell says offshore moves help margin after two-to-three quarters of duplicate costs, and that the funnel keeps shrinking 1.5-2.5% into next year. With offshoring now a multi-year revenue suppressant, when specifically does the promised gross-margin uplift become visible in the consolidated numbers, and how much is it worth in basis points?
Is the 350bps iX Suite Margin Uplift Verifiable?
Management asserts iX-deployed clients carry ~350bps higher margin and that 11% of revenue is 'influenced.' These are the crux of whether the mix-shift is accretive, yet there is no third-party confirmation and no disclosed client cohort. Will the company provide segment-level economics so investors can model the AI margin contribution rather than take it on faith?
What Breaks the Fifth-Consecutive Back-Half Pattern?
The 'sequential ramp' has been promised and missed across five quarters. The FY26 guide again loads recovery into a Q4 near 13% off an 11.9% base. What is structurally different this time, and what is the contingency if Q3's ~12.1% guide holds but Q4 falls short again?
Healthcare: Plan or Drift?
Healthcare has declined for six straight quarters and the rate worsened to -14%. Beyond citing open-enrollment volumes, is there a concrete corrective plan with milestones, or is this vertical being allowed to run off?